Delivery Order SPE2DB22D1002-SPE2DB24FLCV4

Award Date 5/29/24
Potential Completion Date 5/30/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,630.49 fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive medication. The contract has an ultimate completion date of January 5, 2024 and was awarded on January 4, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,767.44, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a transdermal contraceptive patch. The contract is a Firm Fixed Price Delivery Order with a completion date of February 3, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,137.76 Firm Fixed Price Delivery Order contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a transdermal contraceptive patch. The contract has an ultimate completion date of September 27, 2024 and does not utilize any set-aside requirements, indicating open competition. AmerisourceBergen, the prime...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,538.32 firm-fixed-price contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive patch, with a completion date of June 28, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,582.35 delivery order contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a type of contraceptive patch. The contract has a period of performance that runs through December 1, 2023 and uses a Firm Fixed Price pricing structure. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $2,097.54, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive patch. This is a firm fixed-price delivery order contract with a completion date of December 5, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,666.66 firm-fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive patch. The contract has an ultimate completion date of November 4, 2024 and was awarded on November 1, 2022. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The $7,630.15 Firm Fixed Price Delivery Order contract is for the provision of XULANE 150-35 MCG/DAY PATCH 3S, a type of contraceptive patch, with a period of performance through January 5, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,238.60 firm fixed-price contract is for the provision of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive patch. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $8,064.59 contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive patch. The award has a completion date of September 25, 2024 and does not utilize any set-aside designations. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FLCV4
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,268.37, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a type of contraceptive patch. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 30, 2024. The contract was awarded on May 29, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, with no major subcontractors listed. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/16/25, 11:51 AM